KPTI
Karyopharm Therapeutics Inc.
0.00 (0.00%)1.70USD424K成交股數38.6M市值–本益比(近四季)0.3股價營收比-11.9%營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 1K · 2 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 40K |
| 近 180 天 淨額 | −40K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 09-02 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 19 | 2.02 | 38.38 | 23.8K | SEC |
| 2026-07-28 | 07-30 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 189 | 7.10 | 1K | 94.6K | SEC |
| 2026-05-21 | 05-26 | Greene Barry E | Director | A 獲配股票 | 15.5K | – | – | 16.4K | SEC |
| 2026-05-21 | 05-26 | BOHLIN GAREN G | Director | A 獲配股票 | 15.5K | – | – | 18.5K | SEC |
| 2026-05-21 | 05-26 | Schor Chen | Director | A 獲配股票 | 15.5K | – | – | 15.5K | SEC |
| 2026-05-21 | 05-26 | PAKIANATHAN DEEPIKA | Director | A 獲配股票 | 15.5K | – | – | 15.5K | SEC |
| 2026-05-21 | 05-26 | Oliger Christy J. | Director | A 獲配股票 | 15.5K | – | – | 15.5K | SEC |
| 2026-05-21 | 05-26 | Su Zhen | Director | A 獲配股票 | 15.5K | – | – | 15.5K | SEC |
| 2026-05-14 | 05-15 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 53 | 9.50 | 503.50 | 23.8K | SEC |
| 2026-05-14 | 05-15 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 2.2K | 9.50 | 21K | 270K | SEC |
| 2026-05-14 | 05-15 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 403 | 9.50 | 4K | 94.8K | SEC |
| 2026-05-14 | 05-15 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 408 | 9.50 | 4K | 56.8K | SEC |
| 2026-05-14 | 05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S 公開市場賣出 | 324 | 9.50 | 3K | 108K | SEC |
| 2026-05-14 | 05-15 | Mano Michael | EVP, CLO&Secretary | S 公開市場賣出 | 266 | 9.50 | 3K | 94.4K | SEC |
| 2026-05-13 | 05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 947 | – | – | 108K | SEC |
| 2026-05-13 | 05-15 | Abate Kristin | Chief Accounting Officer | A 獲配股票 | 121 | – | – | 23.9K | SEC |
| 2026-05-13 | 05-15 | Mano Michael | EVP, CLO&Secretary | A 獲配股票 | 700 | – | – | 94.7K | SEC |
| 2026-05-13 | 05-15 | Paulson Richard A. | President and CEO | A 獲配股票 | 4.9K | – | – | 272K | SEC |
| 2026-05-13 | 05-15 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 896 | – | – | 95.2K | SEC |
| 2026-05-13 | 05-15 | Rangwala Reshma | EVP & Chief Medical Officer | A 獲配股票 | 947 | – | – | 57.2K | SEC |
| 2026-04-21 | 04-22 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 449 | 8.94 | 4K | 56.3K | SEC |
| 2026-03-02 | 03-03 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 12.4K | 9.41 | 116K | 267K | SEC |
| 2026-03-02 | 03-03 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 559 | 9.41 | 5K | 22.1K | SEC |
| 2026-03-02 | 03-03 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 5.1K | 9.41 | 48K | 94.3K | SEC |
| 2026-03-02 | 03-03 | Mano Michael | EVP, CLO&Secretary | S 公開市場賣出 | 3.5K | 9.41 | 33K | 94.0K | SEC |
| 2026-03-02 | 03-03 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S 公開市場賣出 | 4.6K | 9.41 | 43K | 107K | SEC |
| 2026-03-02 | 03-03 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 5.1K | 9.41 | 48K | 56.7K | SEC |
| 2026-02-17 | 02-19 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 378 | 8.63 | 3K | 99.4K | SEC |
| 2026-02-05 | 02-09 | Paulson Richard A. | President and CEO | A 獲配股票 | 81.1K | – | – | 279K | SEC |
| 2026-02-03 | 02-04 | Macomber Lori | EVP, CFO & Treasurer | S 公開市場賣出 | 1.6K | 6.30 | 10K | 85.1K | SEC |
| 2026-01-31 | 02-03 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 32.4K | – | – | 99.8K | SEC |
| 2026-01-31 | 02-03 | Mano Michael | EVP, CLO&Secretary | A 獲配股票 | 32.4K | – | – | 97.5K | SEC |
| 2026-01-31 | 02-03 | Macomber Lori | EVP, CFO & Treasurer | A 獲配股票 | 32.4K | – | – | 86.7K | SEC |
| 2026-01-31 | 02-03 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 32.4K | – | – | 112K | SEC |
| 2026-01-31 | 02-03 | Rangwala Reshma | EVP & Chief Medical Officer | A 獲配股票 | 32.4K | – | – | 61.8K | SEC |
| 2026-01-28 | 01-29 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 50 | 7.03 | 351.50 | 22.6K | SEC |
| 2026-01-27 | 01-29 | Abate Kristin | Chief Accounting Officer | A 獲配股票 | 92 | – | – | 22.7K | SEC |
| 2026-01-21 | 01-22 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 265 | 5.96 | 2K | 22.6K | SEC |
| 2025-10-15 | 10-16 | Paulson Richard A. | President and CEO | A 獲配股票 | 114K | – | – | 198K | SEC |
| 2025-10-15 | 10-16 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 43.6K | – | – | 79.5K | SEC |
| 2025-10-15 | 10-16 | Abate Kristin | Chief Accounting Officer | A 獲配股票 | 12.8K | – | – | 22.8K | SEC |
| 2025-10-15 | 10-16 | Macomber Lori | EVP, CFO & Treasurer | A 獲配股票 | 43.6K | – | – | 54.3K | SEC |
| 2025-10-15 | 10-16 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 39.7K | – | – | 67.4K | SEC |
| 2025-10-15 | 10-16 | Mano Michael | SVP, General Counsel&Secretary | A 獲配股票 | 43.6K | – | – | 65.1K | SEC |
| 2025-10-01 | 10-03 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 362 | 6.30 | 2K | 10.0K | SEC |
| 2025-09-15 | 09-16 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 1.3K | 6.43 | 8K | 84.0K | SEC |
| 2025-09-15 | 09-16 | Mano Michael | SVP, General Counsel&Secretary | S 公開市場賣出 | 234 | 6.43 | 2K | 21.4K | SEC |
| 2025-09-15 | 09-16 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 401 | 6.43 | 3K | 27.7K | SEC |
| 2025-09-15 | 09-16 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 408 | 6.43 | 3K | 29.4K | SEC |
| 2025-09-15 | 09-16 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S 公開市場賣出 | 325 | 6.43 | 2K | 35.9K | SEC |
| 2025-09-15 | 09-16 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 23 | 6.43 | 147.89 | 10.4K | SEC |
| 2025-09-12 | 09-16 | Abate Kristin | Chief Accounting Officer | A 獲配股票 | 46 | – | – | 10.4K | SEC |
| 2025-09-12 | 09-16 | Paulson Richard A. | President and CEO | A 獲配股票 | 2.8K | – | – | 85.3K | SEC |
| 2025-09-12 | 09-16 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 945 | – | – | 36.2K | SEC |
| 2025-09-12 | 09-16 | Mano Michael | SVP, General Counsel&Secretary | A 獲配股票 | 612 | – | – | 21.7K | SEC |
| 2025-09-12 | 09-16 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 888 | – | – | 28.1K | SEC |
| 2025-09-12 | 09-16 | Rangwala Reshma | EVP & Chief Medical Officer | A 獲配股票 | 945 | – | – | 29.8K | SEC |
| 2025-09-03 | 09-04 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 12 | 6.78 | 81.36 | 9.5K | SEC |
| 2025-07-29 | 07-30 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 191 | 4.37 | 834.67 | 27.2K | SEC |
| 2025-07-22 | 07-23 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 238 | 4.00 | 952.00 | 9.5K | SEC |
| 2025-05-06 | 05-07 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 236 | 7.12 | 2K | 82.5K | SEC |
| 2025-04-23 | 04-24 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 419 | 6.17 | 3K | 28.9K | SEC |
| 2025-04-04 | 04-07 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 245 | 3.74 | 916.30 | 82.7K | SEC |
| 2025-03-04 | 03-06 | Mano Michael | SVP, General Counsel&Secretary | S 公開市場賣出 | 2.8K | 6.29 | 18K | 21.0K | SEC |
| 2025-03-04 | 03-06 | Rangwala Reshma | EVP & Chief Medical Officer | S 公開市場賣出 | 3.6K | 6.29 | 23K | 29.3K | SEC |
| 2025-03-04 | 03-06 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S 公開市場賣出 | 3.4K | 6.29 | 22K | 34.3K | SEC |
| 2025-03-04 | 03-06 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 3.5K | 6.29 | 22K | 27.4K | SEC |
| 2025-03-04 | 03-06 | Abate Kristin | Chief Accounting Officer | S 公開市場賣出 | 571 | 6.29 | 4K | 9.7K | SEC |
| 2025-03-04 | 03-06 | Paulson Richard A. | President and CEO | S 公開市場賣出 | 11.7K | 6.29 | 74K | 83.0K | SEC |
| 2025-02-28 | 03-04 | Mano Michael | SVP, General Counsel&Secretary | A 獲配股票 | 2.3K | – | – | 23.8K | SEC |
| 2025-02-28 | 03-04 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 5.4K | – | – | 33.2K | SEC |
| 2025-02-28 | 03-04 | Rangwala Reshma | EVP & Chief Medical Officer | A 獲配股票 | 4.6K | – | – | 32.9K | SEC |
| 2025-02-28 | 03-04 | Rangwala Reshma | EVP & Chief Medical Officer | A 獲配股票 | 5.4K | – | – | 28.3K | SEC |
| 2025-02-28 | 03-04 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 4.6K | – | – | 31.0K | SEC |
| 2025-02-28 | 03-04 | Poulton Stuart | EVP, Chief Development Officer | A 獲配股票 | 5.0K | – | – | 26.4K | SEC |
| 2025-02-28 | 03-04 | Abate Kristin | Chief Accounting Officer | A 獲配股票 | 933 | – | – | 10.3K | SEC |
| 2025-02-28 | 03-04 | Paulson Richard A. | President and CEO | A 獲配股票 | 20.0K | – | – | 94.7K | SEC |
| 2025-02-28 | 03-04 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A 獲配股票 | 4.6K | – | – | 37.8K | SEC |
| 2025-02-28 | 03-04 | Mano Michael | SVP, General Counsel&Secretary | A 獲配股票 | 3.3K | – | – | 21.6K | SEC |
| 2025-02-18 | 02-19 | Poulton Stuart | EVP, Chief Development Officer | S 公開市場賣出 | 5.9K | 0.63 | 4K | 321K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.9M | 18.7M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.5M | 14.9M | 新進 | 新進 |
| ACORN CAPITAL ADVISORS, LLC | 1.5M | 14.8M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.4M | 13.9M | 新進 | 新進 |
| BlackRock, Inc. | 1.4M | 13.9M | 新進 | 新進 |
| Kalehua Capital Management LLC | 1.4M | 13.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 959K | 9.4M | 新進 | 新進 |
| Catalio Capital Management, LP | 941K | 9.2M | 新進 | 新進 |
| Avidity Partners Management LP | 924K | 9.0M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 695K | 6.8M | 新進 | 新進 |
| NEA Management Company, LLC | 577K | 5.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 531K | 5.2M | 新進 | 新進 |
| Ghisallo Capital Management LLC | 500K | 4.9M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 440K | 4.3M | 新進 | 新進 |
| UBS Group AG | 354K | 3.5M | 新進 | 新進 |
| STATE STREET CORP | 326K | 3.2M | 新進 | 新進 |
| Affinity Asset Advisors, LLC | 313K | 3.1M | 新進 | 新進 |
| Brevan Howard Capital Management LP | 310K | 3.0M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 306K | 3.0M | 新進 | 新進 |
| Boxer Capital Management, LLC | 303K | 3.0M | 新進 | 新進 |
| Davidson Kempner Capital Management LP | 300K | 2.9M | 新進 | 新進 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 297K | 2.9M | 新進 | 新進 |
| Eversept Partners, LP | 276K | 2.7M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 208K | 2.1M | 新進 | 新進 |
| MORGAN STANLEY | 203K | 2.0M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 96 +20 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 96 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 21.8M · 96.1% |
| 合計季末市值 | 201M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.8M |
|---|---|
| 與上期比 | +1.8% |
| 佔流通股數 | 43.27% |
| 日均成交量 | 1.0M |
| 回補天數 | 9.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.8M | +1.8% | 43.27% | 1.0M | 9.4 |
| 2026-08-14 | 9.6M | +27.6% | 42.51% | 2.2M | 4.5 |
| 2026-07-31 | 7.6M | +19.7% | 33.31% | 2.8M | 2.7 |
| 2026-07-15 | 6.3M | -4.1% | 27.83% | 369K | 17.1 |
| 2026-06-30 | 6.6M | +17.9% | 29.03% | 722K | 9.1 |
| 2026-06-15 | 5.6M | +4.4% | 24.62% | 333K | 16.8 |
| 2026-05-29 | 5.3M | +1.4% | 23.58% | 449K | 11.9 |
| 2026-05-15 | 5.3M | -0.3% | 23.26% | 458K | 11.5 |
| 2026-04-30 | 5.3M | -7.4% | 23.34% | 365K | 14.5 |
| 2026-04-15 | 5.7M | +4.8% | 25.21% | 636K | 9.0 |
| 2026-03-31 | 5.5M | +51.9% | 24.06% | 2.4M | 2.3 |
| 2026-03-13 | 3.6M | +20.9% | 15.84% | 714K | 5.0 |
| 2026-02-27 | 3.0M | +20.5% | 13.10% | 516K | 5.8 |
| 2026-02-13 | 2.5M | +82.5% | 10.87% | 854K | 2.9 |
| 2026-01-30 | 1.4M | +81.7% | 5.96% | 342K | 4.0 |
| 2026-01-15 | 744K | +110.2% | 3.28% | 504K | 1.5 |
| 2025-12-31 | 354K | +18.3% | 1.56% | 279K | 1.3 |
| 2025-12-15 | 299K | -12.3% | 1.32% | 225K | 1.3 |
| 2025-11-28 | 341K | -52.4% | 1.51% | 114K | 3.0 |
| 2025-11-14 | 716K | +10.5% | 3.16% | 97.7K | 7.3 |
| 2025-10-31 | 648K | -54.9% | 2.86% | 138K | 4.7 |
| 2025-10-15 | 1.4M | -36.2% | 6.34% | 434K | 3.3 |
| 2025-09-30 | 2.3M | +2.4% | 9.95% | 115K | 19.6 |
| 2025-09-15 | 2.2M | +1.0% | 9.72% | 73.0K | 30.2 |
| 2025-08-29 | 2.2M | +1.7% | 9.62% | 140K | 15.6 |
| 2025-08-15 | 2.1M | +0.8% | 9.45% | 271K | 7.9 |